Search by Drug Name or NDC
NDC 00143-9746-10 Terbutaline Sulfate 1 mg/mL Details
Terbutaline Sulfate 1 mg/mL
Terbutaline Sulfate is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is TERBUTALINE SULFATE.
MedlinePlus Drug Summary
Terbutaline injection is used to treat wheezing, shortness of breath, coughing, and chest tightness caused by asthma, chronic bronchitis, and emphysema. Terbutaline is in a class of medications called beta agonists. It works by relaxing and opening the airways, making it easier to breathe.
Related Packages: 00143-9746-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Terbutaline Injection
Product Information
| NDC | 00143-9746 |
|---|---|
| Product ID | 0143-9746_3e8736f7-de5c-4906-851f-6a10a53866ad |
| Associated GPIs | 44201060202005 |
| GCN Sequence Number | 054007 |
| GCN Sequence Number Description | terbutaline sulfate VIAL 1 MG/ML SUBCUT |
| HIC3 | J5D |
| HIC3 Description | BETA-ADRENERGIC AGENTS |
| GCN | 21815 |
| HICL Sequence Number | 002071 |
| HICL Sequence Number Description | TERBUTALINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Terbutaline Sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Terbutaline Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/mL |
| Substance Name | TERBUTALINE SULFATE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078630 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00143-9746-10 (00143974610)
| NDC Package Code | 0143-9746-10 |
|---|---|
| Billing NDC | 00143974610 |
| Package | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
| Marketing Start Date | 2009-05-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |